WAT vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

WAT

41.4
AI Score
VS
MEDP Wins

MEDP

46.2
AI Score

Investment Advisor Scores

WAT

41score
Recommendation
HOLD

MEDP

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric WAT MEDP Winner
Revenue 2.91B 1.41B WAT
Net Income -208.00M 245.23M MEDP
Net Margin -7.1% 17.3% MEDP
Operating Income -134.00M 288.33M MEDP
ROE -1.4% 56.5% MEDP
ROA -0.8% 11.9% MEDP
Total Assets 24.75B 2.06B WAT
Cash 539.00M 502.69M WAT
Current Ratio 1.86 0.73 WAT

Relative Price Performance (Last 90 Days)

WAT 1M: +7.5% · 3M: +19.6% MEDP 1M: +5.1% · 3M: +9.4%

Current Technical Phase

WAT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 66

RSI (14): 65.9 · Price: $457.47

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 68

RSI (14): 68.2 · Price: $662.48

Fundamentals Snapshot

Metric WAT MEDP
Market Cap — —
Forward P/E 27.7 34.3
Trailing P/E 112.1 36.5
Revenue (TTM) — —
Revenue Growth 1.1% 0.2%
Gross Margin 0.6% 0.7%
Operating Margin 0.1% 0.2%
EPS 3.95 17.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.